TDO has been shown to have immunomodulatory properties that promote tumor immune resistance and proliferation, therefore, TDO is considered a potential cancer treatment target due to the similar roles of TDO and IDO in regulating the Kyn pathway (Abdel-Magid, 2017). This evidence concerns the gene IDO1 and neoplasm.